Researchers from U of T Engineering have discovered that an active, rather than passive, process dictates which nanoparticles enter solid tumors. The finding upends previous thinking in the field of cancer nanomedicine and points toward more effective nanotherapies.
Click here for original story, Most engineered nanoparticles enter tumours through cells, not between them
Source: Phys.org